Search
for
Sort by
Research 181–210 of 1000+
- Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- The Impact of Sulforaphane on Sex-Specific Conditions and Hormone Balance: A Comprehensive Review
- Levonorgestrel effects on serum androgens, sex hormone–binding globulin levels, hair shaft diameter, and sexual function
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe?
- Therapeutic Androgen Receptor Ligands
- The Neurobiology of Sexual Function
- Insulin Resistance and Polycystic Ovary Syndrome
- Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
- Dermatologic manifestations of endocrine disorders
- Current evaluation of amenorrhea
- EFFECTS OF HORMONAL THERAPY IN TRANSGENDERS
- Nonclassic congenital adrenal hyperplasia
- Androgenisierung
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Testosterone therapy for transgender men
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Diseases of the Canine Prostate Gland
- Ketoconazole use in the treatment of ovarian hyperandrogenism
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- Treatment options for polycystic ovary syndrome
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- Unusual presentation with polymenorrhagia and markedly high 17-hydroxy progesterone levels in a lady with Non-Classic Congenital Adrenal Hyperplasia.
- Role of OCT4 in the Regulation of FSH-Induced Granulosa Cells Growth in Female Mice
- Postmenopausal hyperandrogenism
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- Characterizing Dermatological Conditions in the Transgender Population: A Cross-Sectional Study
- Dermatological care of gender‐diverse patients in Australia
- An update of polycystic ovary syndrome: causes and therapeutics options